Let’s play 'Who wants to be a CEO!'

Cara Livernois | | Health Exec | Management

Forbes compiled a list of a sensible, research-based career steps to land the top job, with tips to help in any industry, even for those who've set their sights high in the healthcare industry.

“The qualities a board looks for are really capabilities—and they can manifest themselves differently in different people. Inevitably the capabilities reflect a cluster of skills, knowledge and behaviors. Also, board decisions always involve trade-offs. No candidate is brilliant in everything, and committees will also consider how a candidate’s strengths complement the team he or she will work with. But the core five capabilities are still the basis of what they probe,” said Cathy Anterasian, Spencer Stuart’s Senior Partner and Practice Leader of CEO Succession in North America.

For the full story, click the link below:

Want To Be A CEO? Five Essential Qualities Boards Look For

""
Cara Livernois, News Writer

Cara joined TriMed Media in 2016 and is currently a Senior Writer for Clinical Innovation & Technology. Originating from Detroit, Michigan, she holds a Bachelors in Health Communications from Grand Valley State University.

Related Content

Q&A: Proposed changes to Social Security Act would recognize pharmacists as healthcare providers
FDA issues Class I recall on counterfeit infusion pump batteries
FDA issues alert on PCNL sheath safety after patient death
Bipartisan bills in Congress would force insurance companies, PBMs to sell pharmacies
Anthem BCBS reverses course on anesthesia time limits
FDA issues Class I recall on insulin syringes due to risk of death

Around the web

Cardiovascular Business
FDA says years-long tirzepatide shortage is resolved, will give limited leeway to compounders

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

AI in Healthcare
From Capitol Hill to a hospital near you? 5 federal recommendations for healthcare AI policy

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Cardiovascular Business
Merck spends up to $2B to license new weight loss drug with potential heart benefits

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.